Regensburg (ots) - What started in 1999 as a dedicated gene synthesis provider, turned now into a versatile development lab for the biotech industry. With the launch of its first product and services catalog in 2010, Entelechon has taken the last step on a long road: By gradually expanding into bioinformatics, molecular biology, protein expression and protein quantification, and taking on board a wide range of bioproducts - from antibodies to synthetic peptides - Entelechon can now offer solutions to biotechnological development problems.
Says Dr. Deininger, Managing Director: "We have come a long way. It's not easy for a startup to stay ahead in this international market. By listening to customers and focusing on key trends in biotechnology, we were able to transform Entelechon from small service provider with a single business field - gene synthesis - to a versatile development lab that takes on very complex projects." Entelechon's success factor is the diverse team of experts which allows the company to cover all aspects of a client project and provide turnkey solutions. Markus Fischer, Managing Director and head of the bioinformatics unit, has this to say: "I am very happy about our interdisciplinary and diverse team of experts. This diversity is what drives our success and what allows us to provide unique and very successful solutions." A good example of such a solution is the development of a multiplex PCR assay for the detection of chromosomal aberrations. The assay development required the involvement of the DNA synthesis lab, the molecular biology lab and the bioinformatics unit of Entelechon to work closely together. In the end, the client happily received a very robust and sensitive test kit.
About Entelechon
Entelechon is an internationally operating biotech service provider specialized in synthetic biology. Entelechon started in 1999 as one of the first companies offering custom DNA synthesis.
Originaltext: Entelechon GmbH Digitale Pressemappe: http://www.presseportal.de/pm/79410 Pressemappe via RSS : http://www.presseportal.de/rss/pm_79410.rss2
Pressekontakt: Entelechon GmbH St. Veit-Weg 2 93053 Regensburg Tel +49 941 6981810 Fax +49 941 6981828 Eva Jouaux info@entelechon.com
Says Dr. Deininger, Managing Director: "We have come a long way. It's not easy for a startup to stay ahead in this international market. By listening to customers and focusing on key trends in biotechnology, we were able to transform Entelechon from small service provider with a single business field - gene synthesis - to a versatile development lab that takes on very complex projects." Entelechon's success factor is the diverse team of experts which allows the company to cover all aspects of a client project and provide turnkey solutions. Markus Fischer, Managing Director and head of the bioinformatics unit, has this to say: "I am very happy about our interdisciplinary and diverse team of experts. This diversity is what drives our success and what allows us to provide unique and very successful solutions." A good example of such a solution is the development of a multiplex PCR assay for the detection of chromosomal aberrations. The assay development required the involvement of the DNA synthesis lab, the molecular biology lab and the bioinformatics unit of Entelechon to work closely together. In the end, the client happily received a very robust and sensitive test kit.
About Entelechon
Entelechon is an internationally operating biotech service provider specialized in synthetic biology. Entelechon started in 1999 as one of the first companies offering custom DNA synthesis.
Originaltext: Entelechon GmbH Digitale Pressemappe: http://www.presseportal.de/pm/79410 Pressemappe via RSS : http://www.presseportal.de/rss/pm_79410.rss2
Pressekontakt: Entelechon GmbH St. Veit-Weg 2 93053 Regensburg Tel +49 941 6981810 Fax +49 941 6981828 Eva Jouaux info@entelechon.com
© 2010 news aktuell
